Viewing Study NCT03620318


Ignite Creation Date: 2025-12-25 @ 4:41 AM
Ignite Modification Date: 2026-03-05 @ 4:55 PM
Study NCT ID: NCT03620318
Status: AVAILABLE
Last Update Posted: 2024-08-09
First Post: 2018-08-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Individual Patient Compassionate Use of Crenolanib
Sponsor: Arog Pharmaceuticals, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None FLT3-ITD Mutation View
None FLT3/TKD Mutation View
None PDGFR-Alpha D842V View
None PDGFRA Gene Amplification View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Compassionate use View